Jacon Medical Research Assoc is categorized under Commercial Medical Research in Houston, TX and active since 2007.
Jacon Medical Research Assoc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Robert Jackson, President at the company’s single location by writing to 6550 Fannin St # 2323, Houston, Texas TX 77030 or by phoning (713) 791-9305. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Jacon Medical Research Assoc |
Contact Person: | Robert Jackson, President |
Address: | 6550 Fannin St # 2323, Houston, Texas 77030 |
Phone Number: | (713) 791-9305 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 6211110 |
Share This Business: |
Jacon Medical Research Assoc was started in 2007 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Jackson, President for inquiries that concern Jacon Medical Research Assoc by calling the company number (713) 791-9305, as your correspondence is most welcome. Additionally, the physical location of the single location of Jacon Medical Research Assoc can be found at the coordinates 29.711694,-95.399383 as well as the street address 6550 Fannin St # 2323 in Houston, Texas 77030.
For its online presence, you may visit Jacon Medical Research Assoc’s website at and engage with its social media outlets through on Twitter and on Facebook.